Zacks Investment Research on MSN
Is Invesco Biotechnology & Genome ETF (PBE) a strong ETF right now?
Designed to provide broad exposure to the Health Care ETFs category of the market, the Invesco Biotechnology & Genome ETF (PBE) is a smart beta exchange traded fund launched on 06/23/2005. What Are ...
Scientists at the Department of Energy's Oak Ridge National Laboratory have created a platform that pinpoints genetic ...
Buffett’s casino comments raise an uncomfortable truth. Is biotechnology an investment, or is it more of a gambling casino? The honest answer is that it can be either.
"Biotechnology" is a term commonly applied to the development of new medicines and therapies, the development of genetically modified plants, biofuels, biological treatment, or the production of ...
Microbial biotechnology is a dynamic field, The origins of microbiology can be traced back to the pioneering research by scientists such as Louis Pasteur and Robert Koch in the 19 th century. Within a ...
Zacks Investment Research on MSN
Is Puma Biotechnology (PBYI) a great value stock right now?
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...
IASO Biotechnology ('IASO Bio) today announced the completion of its acquisition of MediSix Therapeutics ('MediSix'), a Singapore-based immune cell engineering and cell therapy company.
Battelle recently welcomed members of the National Security Commission on Emerging Biotechnology (NSCEB) to its Columbus headquarters as part of the NSCEB’s national roadshow providing an inside look ...
Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...
Operator: Hello and welcome to Vir Biotechnology's Second Quarter 2026 Financial Results and Corporate Update Conference Call. As a reminder, this call is being recorded. [Operator Instructions] I ...
Updated Phase 1 dose-escalation data (n=58) show VIR-5500 monotherapy has a favorable safety profile and was well tolerated with no dose-limiting toxicities observed to date - Dose-dependent anti-tumo ...
Biotechnology advances offer immense public health and consumer potential, but come with serious risks. A recent workshop held by the Council on Foreign Relations brought experts together to discuss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results